HomeSTX • LON
add
Shield Therapeutics PLC
Previous close
GBX 2.50
Day range
GBX 2.32 - GBX 2.50
Year range
GBX 1.06 - GBX 7.70
Market cap
25.00M GBP
Avg Volume
1.46M
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 6.07M | 224.13% |
Operating expense | 9.76M | 47.85% |
Net income | -7.74M | -22.79% |
Net profit margin | -127.58 | 62.12% |
Earnings per share | — | — |
EBITDA | -6.92M | -25.67% |
Effective tax rate | 0.01% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.10M | -40.42% |
Total assets | 46.76M | 12.23% |
Total liabilities | 46.22M | 217.34% |
Total equity | 541.00K | — |
Shares outstanding | 782.06M | — |
Price to book | ∞ | — |
Return on assets | -37.58% | — |
Return on capital | -85.67% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -7.74M | -22.79% |
Cash from operations | -1.78M | 82.08% |
Cash from investing | -404.50K | 38.62% |
Cash from financing | -949.50K | -106.30% |
Net change in cash | -2.92M | -157.39% |
Free cash flow | -4.81M | -13.04% |
About
CEO
Founded
2008
Website
Employees
73
